Studying the Clinical Trial Experiences of Patients With Mesothelioma

Primary Outcome Measures

1. Rate of patients who decide to enroll in a mesothelioma medical study. [ Time Frame: 3 months ]
2. Number of mesothelioma patients who remain in clinical trial until completion. [ Time Frame: 12 months ]

Inclusion Criteria

• Must have a medical diagnosis of mesothelioma that has been confirmed by a physician.
• Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed.
• Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.

Exclusion Criteria

• Pregnant or lactating woman
• Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent.
• Known medical condition that, in the investigator’s opinion, would increase the risk associated with study participation or study drug(s) administration or interfere with the interpretation of safety results